BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28881814)

  • 1. Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis.
    Hyun JW; Park JH; Kang BG; Park EY; Park B; Joo J; Kim JK; Kim SH; Jeong JH; Lee HW; Park KD; Choi KG; Hwang SH; Gwak HS; Kim HJ
    Oncotarget; 2017 Aug; 8(32):53326-53335. PubMed ID: 28881814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study.
    Hyun JW; Shin HS; Kim SH; Kong SY; Yoo H; Gwak HS; Kim HJ
    Cancer Biomark; 2020; 28(1):81-89. PubMed ID: 32176621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors.
    Shim Y; Gwak HS; Kim S; Joo J; Shin SH; Yoo H
    J Korean Neurosurg Soc; 2016 Nov; 59(6):570-576. PubMed ID: 27847569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.
    Yoo BC; Lee JH; Kim KH; Lin W; Kim JH; Park JB; Park HJ; Shin SH; Yoo H; Kwon JW; Gwak HS
    Oncotarget; 2017 Nov; 8(60):101203-101214. PubMed ID: 29254157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
    Ko Y; Gwak HS; Park EY; Joo J; Lee YJ; Lee SH; Kwon JW; Shin SH; Yoo H
    J Neurooncol; 2019 Jul; 143(3):553-562. PubMed ID: 31089925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.
    Rinehardt H; Kassem M; Morgan E; Palettas M; Stephens JA; Suresh A; Ganju A; Lustberg M; Wesolowski R; Sardesai S; Stover D; Vandeusen J; Cherian M; Prieto Eibl MDPG; Miah A; Alnahhas I; Giglio P; Puduvalli VK; Ramaswamy B; Williams N; Noonan AM
    Eur J Breast Health; 2021 Oct; 17(4):371-377. PubMed ID: 34651117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Profiles and Their Changes after Intraventricular Chemotherapy as Prognostic or Predictive Markers for Patients with Leptomeningeal Carcinomatosis.
    Kwon JW; Shim Y; Gwak HS; Park EY; Joo J; Yoo H; Shin SH
    J Korean Neurosurg Soc; 2021 Jul; 64(4):631-643. PubMed ID: 34185980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advancements of Treatment for Leptomeningeal Carcinomatosis.
    Gwak HS; Lee SH; Park WS; Shin SH; Yoo H; Lee SH
    J Korean Neurosurg Soc; 2015 Jul; 58(1):1-8. PubMed ID: 26279806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid neurofilament light chain as a potential prognostic biomarker for leptomeningeal metastasis.
    Hyun JW; Kim Y; Kim KH; Kim SH; Park EY; Youn JH; Yoo H; Gwak HS; Kim HJ
    Oncol Lett; 2022 Dec; 24(6):428. PubMed ID: 36311686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
    Wang P; Piao Y; Zhang X; Li W; Hao X
    Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal carcinomatosis as primary manifestation of pancreatic cancer.
    Trinh VT; Medina-Flores R; Chohan MO
    J Clin Neurosci; 2016 Aug; 30():124-127. PubMed ID: 26972704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis: a Phase II Study.
    Gwak HS; Joo J; Shin SH; Yoo H; Han JY; Kim HT; Yun T; Ro J; Lee JS; Lee SH
    Oncologist; 2014 Oct; 19(10):1044-5. PubMed ID: 25209375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptomeningeal carcinomatosis originating from advanced gastric cancer--a report of three cases and review of the literatures.
    Kusumoto T; Kimura Y; Sugiyama M; Ohta M; Tsutsumi N; Sakaguchi Y; Ikejiri K; Oki E; Saeki H; Morita M; Ikeda T; Furuta T; Maehara Y
    Fukuoka Igaku Zasshi; 2013 Nov; 104(11):456-63. PubMed ID: 24620642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of Leptomeningeal Carcinomatosis Manifesting With Vertigo in the Setting of Intracranial Hypertension.
    Saeed L; Khalil SK; Khalil SK; Madani OA; Al Refai F; Musa M; Adam E; Abu-Obieda H
    Cureus; 2023 Oct; 15(10):e47431. PubMed ID: 38021693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases.
    Jung JM; Kim S; Joo J; Shin KH; Gwak HS; Lee SH
    J Korean Neurosurg Soc; 2012 Sep; 52(3):193-9. PubMed ID: 23115660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
    Gwak HS; Joo J; Kim S; Yoo H; Shin SH; Han JY; Kim HT; Lee JS; Lee SH
    J Thorac Oncol; 2013 May; 8(5):599-605. PubMed ID: 23422833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal Carcinomatosis as the Initial Manifestation of Metastatic Disease diagnosed in Postmortem Examination: A Case Series.
    Balbuena-Merle RI; Santé-Pérez M; Pérez-Berenguer J; Velez-Rosario R; Correa-Rivas M; Jiménez A
    P R Health Sci J; 2019 Mar; 38(1):64-67. PubMed ID: 30924918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian Adenocarcinoma With Leptomeningeal Metastases.
    Bayas A; Kondramashin A; Waheeds S; Swerdloff MA
    Cureus; 2022 Aug; 14(8):e27577. PubMed ID: 36059325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.